In accordance with our data from CerS4 LCK/Cre mice, the level of CD8+ T-cells in the IEL fraction was significantly lower in AOM/DSS-treated CerS4 KO mice than in CerS4 WT mice (Figure 7C). The gene discussed is CD8A; the disease is infectious otitis media.